- The salaries are relatively low for a company of its size.
- Power politics are very prevalent, where colleagues who accomplish a lot are not acknowledged, while those who communicate with their line managers in a more obedient way regardless of their performance are rewarded.
- Promotions and learning opportunities are not distributed fairly.
- Acknowledgement of contributions to patents are often lacking due to managers seeking a bigger share.
- Intransparency and deliberate misinformation on the levels of upper and middle management.
- No proper bonuses. Stock bonuses are kind of a scam and conditions are not communicated properly.
- Instead of rehiring colleagues whose positions became redundant in active positions and training them accordingly like how big pharma in Germany typically do, it was resorted to dismissals and lay-offs.
- Continued promotions and hirings for favored select few while many colleagues simultaneously face lay-offs.
- Very weak and inexperienced workers council.
- Management and HR avoid answering questions.
